| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ... Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007 | 1994 | 2007 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 912 | 2009 |
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ... Cell 140 (5), 652-665, 2010 | 699 | 2010 |
| The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ... Cancer cell 8 (5), 355-368, 2005 | 594 | 2005 |
| Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine W Blum, R Garzon, RB Klisovic, S Schwind, A Walker, S Geyer, S Liu, ... Proceedings of the National Academy of Sciences 107 (16), 7473-7478, 2010 | 588 | 2010 |
| A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic, M Moran, TS Lin, ... Blood 105 (3), 959-967, 2005 | 481 | 2005 |
| FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ... The Journal of clinical investigation 117 (9), 2408-2421, 2007 | 428 | 2007 |
| Curcumin is a potent DNA hypomethylation agent Z Liu, Z Xie, W Jones, RE Pavlovicz, S Liu, J Yu, P Li, J Lin, JR Fuchs, ... Bioorganic & medicinal chemistry letters 19 (3), 706-709, 2009 | 384 | 2009 |
| Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia W Blum, RB Klisovic, B Hackanson, Z Liu, S Liu, H Devine, ... Journal of Clinical Oncology 25 (25), 3884-3891, 2007 | 380 | 2007 |
| Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells J Yu, M Wei, B Becknell, R Trotta, S Liu, Z Boyd, MS Jaung, BW Blaser, ... Immunity 24 (5), 575-590, 2006 | 300 | 2006 |
| CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets J Yu, HC Mao, M Wei, T Hughes, J Zhang, I Park, S Liu, S McClory, ... Blood, The Journal of the American Society of Hematology 115 (2), 274-281, 2010 | 295 | 2010 |
| Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, ... Cancer cell 17 (4), 333-347, 2010 | 288 | 2010 |
| Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia L Yu, C Liu, J Vandeusen, B Becknell, Z Dai, YZ Wu, A Raval, TH Liu, ... Nature genetics 37 (3), 265-274, 2005 | 287 | 2005 |
| Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study S Schwind, K Maharry, MD Radmacher, K Mrózek, KB Holland, ... Journal of clinical oncology 28 (36), 5257, 2010 | 228 | 2010 |
| Close association of RNA polymerase II and many transcription factors with Pol III genes D Raha, Z Wang, Z Moqtaderi, L Wu, G Zhong, M Gerstein, K Struhl, ... Proceedings of the National Academy of Sciences 107 (8), 3639-3644, 2010 | 216 | 2010 |
| Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation A Mishra, S Liu, GH Sams, DP Curphey, R Santhanam, LJ Rush, ... Cancer cell 22 (5), 645-655, 2012 | 212 | 2012 |
| The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted … SP Whitman, S Liu, T Vukosavljevic, LJ Rush, L Yu, C Liu, MI Klisovic, ... Blood 106 (1), 345-352, 2005 | 184 | 2005 |
| Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity G Marcucci, W Stock, G Dai, RB Klisovic, S Liu, MI Klisovic, W Blum, ... Journal of clinical oncology 23 (15), 3404-3411, 2005 | 183 | 2005 |
| Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia S Liu, T Shen, L Huynh, MI Klisovic, LJ Rush, JL Ford, J Yu, B Becknell, ... Cancer research 65 (4), 1277-1284, 2005 | 172 | 2005 |
| A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors F Yan, A Al-Kali, Z Zhang, J Liu, J Pang, N Zhao, C He, MR Litzow, S Liu Cell research 28 (11), 1062-1076, 2018 | 167 | 2018 |
